Beijing Chengyi Pharmaceutical Technology

Beijing Chengyi Pharmaceutical Technology is the dedicated research and development subsidiary of Zhejiang Chengyi Pharmaceutical, a prominent Chinese pharmaceutical manufacturer. Based in Beijing, the company focuses on the innovation and optimization of small molecule drugs, particularly in the fields of joint health, antivirals, and immunosuppressants. It plays a critical role in the parent company's strategy to transition from traditional manufacturing to high-tech pharmaceutical innovation. Key products developed and supported by the group include glucosamine hydrochloride for osteoarthritis and ribavirin for viral infections. The facility serves as a hub for clinical registration, intellectual property management, and advanced formulation research. Additionally, the company is spearheading the development of high-purity omega-3 fatty acids for cardiovascular health. Its strategic location in Beijing allows it to leverage top-tier scientific talent and academic partnerships.